EndoShunt Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $2M

  • Investors
  • 12

EndoShunt General Information

Description

Developer of a medical device designed to control hemorrhage in emergencies. The company's device helps shunt blood past hemorrhaging vessels endovascularly, enabling surgeons to provide a definitive repair while maintaining blood flow.

Contact Information

Website
www.endoshunt.com
Formerly Known As
REBy Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2100 West End Avenue
  • Suite 1300
  • Nashville, TN 37203
  • United States
+1 (781)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Vertical(s)
HealthTech
Corporate Office
  • 2100 West End Avenue
  • Suite 1300
  • Nashville, TN 37203
  • United States
+1 (781)

EndoShunt Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoShunt Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC $2M In Progress Generating Revenue
12. Early Stage VC 01-Jan-2025 Completed Generating Revenue
11. Accelerator/Incubator Completed Generating Revenue
10. Accelerator/Incubator 05-Mar-2024 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
7. Accelerator/Incubator 01-Oct-2023 Completed Generating Revenue
6. Seed Round 01-Apr-2023 Completed Generating Revenue
5. Accelerator/Incubator 20-Mar-2023 $180K $355K Completed Generating Revenue
4. Accelerator/Incubator 19-Dec-2022 $175K Completed Generating Revenue
To view EndoShunt’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

EndoShunt Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

EndoShunt Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12691265-B2 Endovascular shunts and methods of shunting Active 25-Mar-2021
US-20220305241-A1 Endovascular shunts and methods of shunting Active 25-Mar-2021
US-20260335613-A1 Endovascular shunts and methods of shunting Pending 25-Mar-2021 A61M27/002

EndoShunt Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EndoShunt Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
HBS Alumni Angels of Greater New York Angel Group Minority
New York Angels Angel Group Minority
Octerra Capital Venture Capital Minority
TiE Oregon Accelerator/Incubator
Fuel Accelerator Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

EndoShunt FAQs

  • When was EndoShunt founded?

    EndoShunt was founded in 2020.

  • Where is EndoShunt headquartered?

    EndoShunt is headquartered in Nashville, TN.

  • What is the size of EndoShunt?

    EndoShunt has 5 total employees.

  • What industry is EndoShunt in?

    EndoShunt’s primary industry is Surgical Devices.

  • Is EndoShunt a private or public company?

    EndoShunt is a Private company.

  • What is EndoShunt’s current revenue?

    The current revenue for EndoShunt is .

  • How much funding has EndoShunt raised over time?

    EndoShunt has raised $530K.

  • Who are EndoShunt’s investors?

    HBS Alumni Angels of Greater New York, New York Angels, Octerra Capital, TiE Oregon, and Fuel Accelerator are 5 of 12 investors who have invested in EndoShunt.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process